ManageEngine RecoveryManager Plus
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
Comparison · Analytics
DoseFinding vs Plotly
A side-by-side editorial comparison of DoseFinding and Plotly — release velocity, themes, recent moves, and the top alternatives to consider.
DoseFinding vs Plotly: at a glance
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
What is Plotly?
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
Plotly ships on two tracks. Plotly Studio, the desktop AI app-builder, releases every one to two weeks and has spent v0.0.80 through v0.0.86 on credential handling, reasoning transparency, personalization and now the reliability of the agent session engine itself. Plotly Cloud is the louder track: since late May it has added viewer-seat pricing, domain verification, per-app compute modes with credit-metered billing, and customer-owned domains with managed TLS.
DoseFinding vs Plotly: editorial side-by-side
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Plotly
6.3ANALYTICS
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
◆ Current state
Plotly ships on two tracks. Plotly Studio, the desktop AI app-builder, releases every one to two weeks and has spent v0.0.80 through v0.0.86 on credential handling, reasoning transparency, personalization and now the reliability of the agent session engine itself. Plotly Cloud is the louder track: since late May it has added viewer-seat pricing, domain verification, per-app compute modes with credit-metered billing, and customer-owned domains with managed TLS.
◆ Where it's heading
The Cloud releases are assembling the standard pieces of a hosting business in order — identity first (domain verification, explicitly framed as the step before SSO), then billing (viewer seats, then metered compute credits), and now production-grade serving (custom domains, automatic certificate renewal). Studio is being hardened as the authoring front end that feeds it: Universal Deployment pushed beyond Dash apps, credentials saved once and reused, a Winget channel to widen Windows installs, and in v0.0.86 a rebuilt session engine plus automatic retries so agent runs survive expired tokens. The two tracks converge on one funnel — author in Studio, deploy to Cloud, pay by compute consumed.
◆ Prediction
The Domain Verification entry names SSO as the next step and places it in the Enterprise tier, so single sign-on is the most likely Cloud release next. Studio should hold its one-to-two-week cadence, with the newly added app thumbnails pointing toward more work on browsing and organizing generated apps.
Alternatives to DoseFinding and Plotly
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or Plotly.
Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
silx
silx settles into maintenance a release after its PySide6 migration
aniread
aniread stops asking you to know which tracker wrote the file
Rho
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
See all DoseFinding alternatives → · See all Plotly alternatives →
Recent activity from DoseFinding and Plotly
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 15d agoPlotlyCustom Domains in Plotly Cloud ⚡
- 25d agoPlotlyPlotly Studio v0.0.85: Breadcrumbs & minor bug fixes
- 1mo agoPlotlyPlotly Studio v0.0.84: Faster AI, Saved Credentials, and Winget Support
- 1mo agoPlotlyCompute Modes and App Sizing in Plotly Cloud ⚡
- 1mo agoPlotlyPlotly Studio 0.0.83: Dash Update and macOS Fixes
- 2mo agoPlotlyPlotly Studio v0.0.82: Override for credential redaction, stability fixes
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between DoseFinding and Plotly?
They serve adjacent needs but don't currently overlap on shipped themes. Plotly is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DoseFinding better than Plotly?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Plotly is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
What are the best alternatives to Plotly?
Top Plotly alternatives in Analytics are ranked by recent ship velocity. Browse the "Plotly alternatives" section above for the current picks, or visit /alternatives/plotly for the full list with editorial commentary on each.